Entry Point Capital, LLC Procept Bio Robotics Corp Transaction History

Entry Point Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$48.82 - $65.05 $7,078 - $9,432	-145 Reduced 3.69%	3,780 $217,000
Q1 2025 May 14, 2025	SELL	$56.03 - $88.57 $75,528 - $119,392	-1,348 Reduced 25.56%	3,925 $228,000
Q4 2024 Feb 11, 2025	SELL	$67.27 - $99.45 $38,814 - $57,382	-577 Reduced 9.86%	5,273 $424,000
Q3 2024 Nov 13, 2024	BUY	$56.31 - $84.99 $329,413 - $497,191	5,850 New	5,850 $468,000
Q1 2024 May 14, 2024	BUY	$40.38 - $50.75 $1,534 - $1,928	38 Added 4.71%	844 $41.7 Million

Q4 2023 Feb 14, 2024	BUY	$24.89 - $43.41 $20,061 - $34,988	806 New	806 $33.8 Million

272

49.1M

274K

376K

Ticker PRCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 44,592,300
Market Cap $1.32B
Description
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Entry Point Capital, LLC with notifications on news.